Prof. Dr. Udo Gaipl


Medizinische Fakultät

Publications (Download BibTeX)

Go to first page Go to previous page 11 of 12 Go to next page Go to last page

Candeias, S.M., & Gaipl, U. (2015). The Immune System in Cancer Prevention, Development and Therapy. Anti-Cancer Agents in Medicinal Chemistry, 16(1), 101-7.
Kötter, B., Frey, B., Winderl, M., Rubner, Y., Scheithauer, H., Sieber, R.,... Gaipl, U. (2015). The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation. Radiation Oncology, 10, 197.
Sievert, W., Tapio, S., Breuninger, S., Gaipl, U., Andratschke, N., Trott, K.-R., & Multhoff, G. (2014). Adhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferation. PLoS ONE, 9(3), e91808.
Frey, B., Rubner, Y., Kulzer, L., Werthmöller, N., Weiss, E.-M., Fietkau, R., & Gaipl, U. (2014). Antitumor immune responses induced by ionizing irradiation and further immune stimulation. Cancer Immunology Immunotherapy, 63(1), 29-36.
Rubner, Y., Muth, C., Strnad, A., Derer, A., Sieber, R., Buslei, R.,... Gaipl, U. (2014). Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines. Radiation Oncology, 9(1), 89.
Scheithauer, H., Belka, C., Lauber, K., & Gaipl, U. (2014). Immunological aspects of radiotherapy. Radiation Oncology, 9, 185.
Gaipl, U., Multhoff, G., Scheithauer, H., Lauber, K., Hehlgans, S., Frey, B., & Roedel, F. (2014). Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy. Immunotherapy, 6(5), 597-610.
Kulzer, L., Rubner, Y., Deloch, L., Allgäuer, A., Frey, B., Fietkau, R.,... Gaipl, U. (2014). Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells. Journal of Immunotoxicology, 11(4), 328-36.
Ott, O.J., Jeremias, C., Gaipl, U., Frey, B., Schmidt, M., & Fietkau, R. (2014). Radiotherapy for benign calcaneodynia: long-term results of the Erlangen Dose Optimization (EDO) trial. Strahlentherapie und Onkologie, 190(7), 671-5.
Ott, O.J., Hertel, S., Gaipl, U., Frey, B., Schmidt, M., & Fietkau, R. (2014). The Erlangen Dose Optimization trial for low-dose radiotherapy of benign painful elbow syndrome. Long-term results. Strahlentherapie und Onkologie, 190(3), 293-7.

Last updated on 2016-05-05 at 05:15